Charles River 10 juin 2026 Charles River CEO shares “the next big transition” in CRO - Fierce Biotech
Charles River 10 juin 2026 Reasons Why You Should Hold Charles River Stock in Your Portfolio - TradingView
Charles River 9 juin 2026 Assessing Charles River Laboratories (CRL) Valuation After Recent Share Recovery And Conflicting Fair Value Signals - simplywall.st
Charles River 5 juin 2026 Charles River Laboratories names first CEO from outside founding family - The Business Journals
Charles River 4 juin 2026 Charles River Laboratories stock (US1591881009): Insider grant and fresh fund buying keep focus on C - AD HOC NEWS
Charles River 29 mai 2026 Charles River CEO says it likely won’t be the last manufacturer to break away from cell and gene therapy - Endpoints News
Charles River 28 mai 2026 Charles River Laboratories International Jumps 7.9% in Broad Rally - AlphaStreet
Charles River 20 mai 2026 Charles River Laboratories and MEDIPOST, Inc. collaborate to advance GMP testing solutions for cell therapies - BioSpectrum Asia
Charles River 19 mai 2026 A Look At Charles River Laboratories (CRL) Valuation After Recent Share Price Weakness - simplywall.st
Charles River 19 mai 2026 A Look At Charles River Laboratories (CRL) Valuation After Recent Share Price Weakness - simplywall.st
Charles River 19 mai 2026 Charles River Laboratories stock (US1591881009): Fresh earnings and outlook keep investors focused o - AD HOC NEWS
Charles River 18 mai 2026 Drug Development Inputs & Services Stocks Q1 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers - StockStory
Charles River 18 mai 2026 Charles River Laboratories stock (US1591881009): Q1 results, guidance and what matters for investors - AD HOC NEWS
Charles River 17 mai 2026 NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know - Yahoo Finance
Charles River 16 mai 2026 Charles River Labs stock (US14149Y1082): 4.45% slide puts support zone back in focus - AD HOC NEWS
Charles River 15 mai 2026 Charles River Laboratories stock (US1591881009): recent earnings and outlook under the microscope - AD HOC NEWS
Charles River 14 mai 2026 Charles River Laboratories stock (US1591881009): Q1 earnings beat with updated FY guidance - AD HOC NEWS